Big Gain For Marker Therapeutics, Inc.
Tue, Aug 15, 2023 at 07:34 PM
Marker Therapeutics, Inc. (MRKR:NASDAQ) jumped higher at $5.86, a gain of 25.8%. On Tue, Aug 15, 2023, MRKR:NASDAQ hit a New 2-Week High of $5.86. The stock got featured on our News Catalysts scanner on Mon, Aug 14, 2023 at 04:50 PM in the 'INVESTOR UPDATE' category. From Tue, Aug 01, 2023, the stock recorded 40.00% Up Days and 54.55% Green Days
About Marker Therapeutics, Inc. (MRKR:NASDAQ)
TapImmune Inc is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company's next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches.
Top 10 Gainers:
- T2 Biosystems, Inc. (TTOO:NASDAQ), 51.56%
- Paranovus Entertainment Technology Ltd Ord (New) (PAVS:NASDAQ), 36.33%
- Tiziana Life Sciences PLC (TLSA:NASDAQ), 33.94%
- Grove Collaborative Holdings Inc. Class A (GROV:NYSE), 30.14%
- Electrameccanica Vehicles Corp. (SOLO:NASDAQ), 29.9%
- Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ), 27.6%
- Peak Bio Inc Com (PKBO:NASDAQ), 27.48%
- Marker Therapeutics, Inc. (MRKR:NASDAQ), 25.75%
- Siyata Mobile Inc. (SYTA:NASDAQ), 24.4%
- Genesis Unicorn Capital Corp. (GENQ:NASDAQ), 24.05%